This anesthetic drug may cause a rare condition named propofol infusion syndrome, characterized
by unexplained lactic acidosis, lipemia, rhabdomyolysis, cardiovascular collapse and
Brugada-like electrocardiographic pattern or Brugada electrocardiographic phenocopy changes
following high-dose propofol infusion over prolonged periods of time.
Several articles have contributed to our understanding of the cause of the syndrome, and the
growing number of case reports has made it possible to identify several risk factors. Uncertainty
remains as to whether a genetic susceptibility exists.
The favorable recovery profile associated with propofol offers advantages over traditional
anesthetics in clinical situations in which rapid recovery is important. Propofol is a safe
anesthetic agent, but propofol infusion syndrome is a rare lethal complication. (Cardiol J 2010;
17, 2: 130-135
